Guren MG - Search Results

1

E-cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models.

Bruun J, Eide PW, Bergsland CH, Bruck O, Svindland A, Arjama M, Välimäki K, Bjørnslett M, Guren MG, Kallioniemi O, Nesbakken A, Lothe RA, Pellinen T. Bruun J, et al. Among authors: guren mg. Mol Oncol. 2022 Jun;16(12):2312-2329. doi: 10.1002/1878-0261.13159. Epub 2021 Dec 26. Mol Oncol. 2022. PMID: 34890102 Free PMC article.

2

Quality of life and functional outcome following anterior or abdominoperineal resection for rectal cancer.

Guren MG, Eriksen MT, Wiig JN, Carlsen E, Nesbakken A, Sigurdsson HK, Wibe A, Tveit KM; Norwegian Rectal Cancer Group. Guren MG, et al. Eur J Surg Oncol. 2005 Sep;31(7):735-42. doi: 10.1016/j.ejso.2005.05.004. Eur J Surg Oncol. 2005. PMID: 16180267

3

Anticipating the clinical use of prognostic gene expression-based tests for colon cancer stage II and III: is Godot finally arriving?

Sveen A, Nesbakken A, Ågesen TH, Guren MG, Tveit KM, Skotheim RI, Lothe RA. Sveen A, et al. Among authors: guren mg. Clin Cancer Res. 2013 Dec 15;19(24):6669-77. doi: 10.1158/1078-0432.CCR-13-1769. Epub 2013 Oct 28. Clin Cancer Res. 2013. PMID: 24166914

4

Nationwide improvement of rectal cancer treatment outcomes in Norway, 1993-2010.

Guren MG, Kørner H, Pfeffer F, Myklebust TÅ, Eriksen MT, Edna TH, Larsen SG, Knudsen KO, Nesbakken A, Wasmuth HH, Vonen B, Hofsli E, Færden AE, Brændengen M, Dahl O, Steigen SE, Johansen MJ, Lindsetmo RO, Drolsum A, Tollåli G, Dørum LM, Møller B, Wibe A. Guren MG, et al. Acta Oncol. 2015 Nov;54(10):1714-22. doi: 10.3109/0284186X.2015.1034876. Epub 2015 Apr 30. Acta Oncol. 2015. PMID: 25924970

5

Resection of synchronous liver metastases between radiotherapy and definitive surgery for locally advanced rectal cancer: short-term surgical outcomes, overall survival and recurrence-free survival.

Labori KJ, Guren MG, Brudvik KW, Røsok BI, Waage A, Nesbakken A, Larsen S, Dueland S, Edwin B, Bjørnbeth BA. Labori KJ, et al. Among authors: guren mg. Colorectal Dis. 2017 Aug;19(8):731-738. doi: 10.1111/codi.13622. Colorectal Dis. 2017. PMID: 28181384

6

CMS-dependent prognostic impact of KRAS and BRAFV600E mutations in primary colorectal cancer.

Smeby J, Sveen A, Merok MA, Danielsen SA, Eilertsen IA, Guren MG, Dienstmann R, Nesbakken A, Lothe RA. Smeby J, et al. Among authors: guren mg. Ann Oncol. 2018 May 1;29(5):1227-1234. doi: 10.1093/annonc/mdy085. Ann Oncol. 2018. PMID: 29518181 Free PMC article.

7

Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer.

Bruun J, Sveen A, Barros R, Eide PW, Eilertsen I, Kolberg M, Pellinen T, David L, Svindland A, Kallioniemi O, Guren MG, Nesbakken A, Almeida R, Lothe RA. Bruun J, et al. Among authors: guren mg. Mol Oncol. 2018 Sep;12(9):1639-1655. doi: 10.1002/1878-0261.12347. Epub 2018 Aug 15. Mol Oncol. 2018. PMID: 29900672 Free PMC article.

8

Transcriptional and functional consequences of TP53 splice mutations in colorectal cancer.

Smeby J, Sveen A, Eilertsen IA, Danielsen SA, Hoff AM, Eide PW, Johannessen B, Hektoen M, Skotheim RI, Guren MG, Nesbakken A, Lothe RA. Smeby J, et al. Among authors: guren mg. Oncogenesis. 2019 May 15;8(6):35. doi: 10.1038/s41389-019-0141-3. Oncogenesis. 2019. PMID: 31092812 Free PMC article.

9

Exploratory analyses of consensus molecular subtype-dependent associations of TP53 mutations with immunomodulation and prognosis in colorectal cancer.

Smeby J, Sveen A, Bergsland CH, Eilertsen IA, Danielsen SA, Eide PW, Hektoen M, Guren MG, Nesbakken A, Bruun J, Lothe RA. Smeby J, et al. Among authors: guren mg. ESMO Open. 2019 Jun 24;4(3):e000523. doi: 10.1136/esmoopen-2019-000523. eCollection 2019. ESMO Open. 2019. PMID: 31321083 Free PMC article.

10

Heterogeneous radiological response to neoadjuvant therapy is associated with poor prognosis after resection of colorectal liver metastases.

Brunsell TH, Cengija V, Sveen A, Bjørnbeth BA, Røsok BI, Brudvik KW, Guren MG, Lothe RA, Abildgaard A, Nesbakken A. Brunsell TH, et al. Among authors: guren mg. Eur J Surg Oncol. 2019 Dec;45(12):2340-2346. doi: 10.1016/j.ejso.2019.07.017. Epub 2019 Jul 17. Eur J Surg Oncol. 2019. PMID: 31350075 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

102 results

Search Page